Psyence Biomedical Warrant
PBMWW
22 hedge funds and large institutions have $80.2K invested in Psyence Biomedical Warrant in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% less capital invested
Capital invested by funds: $80.5K → $80.2K (-$313)
4.13% less ownership
Funds ownership: 46.98% → 42.85% (-4.1%)
4% less funds holding
Funds holding: 23 → 22 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$2.66K |
| 2 |
VF
Virtu Financial
New York
|
+$672 |
| 3 |
Walleye Trading
New York
|
+$262 |
| 4 |
CS
Clear Street
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.95K |
| 2 |
CSD
Clear Street Derivatives
New York
|
-$2.24K |
| 3 |
Walleye Capital
New York
|
-$2.18K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.88K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$1.25K |
PBMWW Hedge Fund Activity: Q4 2024 in Review
22 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q4 2024, worth a combined $80.2K — down 0.39% from $80.5K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PBMWW and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $2.66K. The largest seller was Context Capital Management, exiting entirely with an estimated $2.95K sold.
- 22 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q4 2024, down from 23 in Q3 2024.
- Funds reported $80.2K of Psyence Biomedical Warrant stock for Q4 2024, down 0.39% quarter-over-quarter.
- 3 funds opened new Psyence Biomedical Warrant positions in Q4 2024 and 4 closed out, a net change of -1 holder.
- The largest Psyence Biomedical Warrant buyer in Q4 2024 was LMR Partners, an estimated $2.66K added.
- The largest Psyence Biomedical Warrant seller in Q4 2024 was Context Capital Management, an estimated $2.95K sold.
Based on aggregated 13F filings for Q4 2024.